BofA Upgrades Schrödinger (SDGR) to Buy After Strategic Pivot to Software

Schrödinger, Inc. (NASDAQ:SDGR) is one of the best healthcare AI stocks to buy now. On December 15, BofA Securities upgraded Schrödinger, Inc. (NASDAQ:SDGR) from Neutral to Buy, with a $24 price target. BofA stated this move is a result of its growing optimism that Schrödinger’s recent pivot away from resource-heavy internal drug development toward its core software business is clearing the path for stronger, more predictable growth. BofA Upgrades Schrödinger (SDGR) to Buy After Strategic Pivot to Softwar ...